scholarly journals Budget Impact Analysis for Nilotinib Use in the Treatment of Chronic Myeloid Leukemia in Colombia

2014 ◽  
Vol 17 (3) ◽  
pp. A75
Author(s):  
M. Romero ◽  
G. Acero ◽  
R. Marrugo
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis

Budget Impact Analysis of Chronic Myeloid Leukemia Treatment in Bulgaria

2013 ◽  
Vol 27 (1) ◽  
pp. 3595-3598 ◽  
Author(s):  
Alexandra Savova ◽  
Maria Kamusheva ◽  
Svetla Georgieva ◽  
Assena Stoimenova ◽  
Guenka Petrova
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Leukemia Treatment

scholarly journals PCN34 BUDGET IMPACT ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) IN BRAZIL

2009 ◽  
Vol 12 (7) ◽  
pp. A262
Author(s):  
E Asano ◽  
M Nita ◽  
A Moellmann-Coelho ◽  
R Rached ◽  
B Donato ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Imatinib Resistant

scholarly journals Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients

2020 ◽  
Vol 111 (7) ◽  
pp. 2526-2535
Author(s):  
Kiyotaka Yamazaki ◽  
Naohito Inagaki ◽  
Daniel Moldaver ◽  
Ricardo Viana ◽  
Shinya Kimura
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Treatment Free Remission
Sign in / Sign up

Export Citation Format

Share Document